Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Dicerna Pharmaceutic (DRNA)

7.84 0.34 (4.53%)

12-13 16:00

Open:

7.5

Pre. Close:

7.5

High:

7.98

Low:

7.5

Volume:

177,247

Market Cap:

163M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.13 - 8.28

8.28 - 8.47

Low:

7.12 - 7.22

7.22 - 7.35

Close:

7.56 - 7.82

7.82 - 8.13

Technical analysis  (as of: 2017-12-13 5:02:27 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 10.67     One year: 11.96

Support:

Support1: 7.35    Support2: 6.12

Resistance:

Resistance1: 9.14    Resistance2: 10.24

Pivot:

8.24

Moving Averages:

MA(5): 7.65     MA(20): 8.58

MA(100): 5.50     MA(250): 4.02

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.29

%K %D:

%K(14,3): 12.00     %D(3): 8.62

RSI:

RSI(14): 49.19

52-Week:

High: 10.24  Low: 2.421  Change(%): 166.7

Average Vol(K):

3-Month: 29052  10-Days 16309

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DRNA has closed above bottom band by 33.8%. Bollinger Bands are 17.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 13 Dec 2017 21:45:00 GMT
Dicerna Pharma (DRNA) Announces Proposed Common Share Offering

Thu, 14 Dec 2017 12:45:00 GMT
What Do Analysts Think About Dicerna Pharmaceuticals Inc's (NASDAQ:DRNA ...

Sat, 04 Nov 2017 00:22:30 GMT
Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q3 2017 Results ...

Tue, 09 May 2017 00:22:30 GMT
Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q1 2017 Results ...

Thu, 07 Dec 2017 12:33:45 GMT
Dicerna Pharma (DRNA) Reports First Human Dosed in Phase 1 Clinical Trial of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

20.85

Shares Float (M)

12.52

% Held by Insiders

1.62

% Held by Institutions

71.33

Shares Short (K)

371

Shares Short Prior Month (K)

380

Stock Financials

EPS

-3.430

EPS Est. Current Year

-2.700

EPS Est. Next Year

-2.760

EPS Est. Next Quarter

-0.690

Forward EPS

-3.111

Book Value (p.s.)

-0.180

PEG Ratio

Profit Margin

Operating Margin

-5936.89

Return on Assets (ttm)

-50.5

Return on Equity (ttm)

-93.3

Qtrly Rev. Growth

192.6

Gross Profit (p.s.)

0.014

Sales Per Share

EBITDA (p.s.)

-2.789

Qtrly Earnings Growth

Operating Cash Flow (M)

-50.96

Levered Free Cash Flow (M)

-29.50

atoplab.com

Valuation

P/E

-2.29

P/E Growth Ratio

0.05

P/BV

-43.56

P/S

3269280000.00

P/CF

-3.21

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.